Recent News

• 03.10.2025 - enGene Reports First Quarter 2025 Financial Results and Provides Business Update
• 03.04.2025 - enGene to Participate in the Leerink Partners Global Healthcare Conference

Recent Filings

• 03.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.05.2025 - AW Amendment Withdrawal Request
• 03.05.2025 - AW Amendment Withdrawal Request
• 03.04.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.04.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.04.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 03.04.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.28.2025 - 497K Summary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(K)
• 02.28.2025 - 497K Summary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(K)
• 02.28.2025 - 497K Summary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(K)